GI & Endoscopy

Laval, Canada-based Valeant Pharmaceuticals' board of directors elected Richard DeSchutter director.

Researchers from Nashville, Tenn.-based Vanderbilt University created an endoscope that uses Raman spectroscopy, a chemical-fingerprinting technique, to detect inflammatory bowel disease in the colon.

A study in Journal of Clinical Gastroenterology investigated the effect of the specific carbohydrate diet on active inflammatory bowel disease, to determine whether diet is an effective therapeutic option.

Here are three updates on gastroenterology and endoscopy companies.

J. Scott Buckley is a gastroenterologist at Indianapolis' Indy Gastro and the medical director of the Franciscan Health endoscopy center, also in Indianapolis.

After a down 2016 in which Laval, Canada-based Valeant Pharmaceuticals slumped 85.3 percent, Zacks Equity Research predicted the stock's future in 2017.

Clifton, N.J.-based EndoLogic acquired the rights to Renzapride from Cambridge, United Kingdom, based- Alizyme.

Namur, Belgium-based VolitionRx's Nu.Q colorectal cancer screening triage test gained a CE mark.

Born with biliary atresia, Ben Blake, 26, underwent his first liver transplant when he was seven-months old. Twenty years later, his liver was failing and he needed a replacement.

Illinois Gastroenterology Group, based in the Chicago area, and SonarMD developed Project Sonar, an intensive medical home model to care for patients with Crohn's disease. The model, applied across the 20-physician specialty group since 2014, has since gathered data to…